Metabolic syndrome and cardiovascular disease in elders: Results of the Mataró Ageing Study;Síndrome metabólico y enfermedad cardiovascular en ancianos: Resultados del Estudio de Envejecimiento de Mataró

Medicina Clinica

Volumn 130, Issue 9, 2008, Pages 327-331

  Alfaro, Sergio Rueda ^a   Serra Prat, Mateu ^b   Fernández, Cristián ^a   Palomera, Elisabet ^b   Puig Domingo, Manuel ^a,b   Ayllon J ^c   Boquet, X ^c   Bosch, A ^c   Burdoy, E ^c   Cademas, I ^c   Dordas, J ^c   Espinosa, C ^c   Falcon I ^c   Gordillo, M ^c   Merino, M J ^c   Mussoll, J ^c   Palomera, E ^c   Papiol, M ^c   Pous, E ^c   Pubill, M ^c   Puig, J ^c   Puig Domingo, M ^c   Sanahuja J ^c   Serra, P ^c   Serra Prat, M ^c   Serrano, C ^c   Vilardebo A ^c   Villarroya, I ^c   more..

^a HOSPITAL CLÍNIC   (Spain)

^b Unidad de Investigacion   (Spain)

^c NONE

Author keywords

Ageing; Cardiovascular disease; Metabolic syndrome

Indexed keywords

AGED; AGING; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EDUCATION; FEMALE; GERIATRIC PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POPULATION RESEARCH; PREVALENCE; SMOKING; STATISTICAL SIGNIFICANCE;

EID: 42049092153     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1157/13117349     Document Type: Article

References (23)

1. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes. 1992;41:715-22.
2. Lorenzo C, Okoloise M, Williams K, Stern M, Haffner S; San Antonio Heart Study. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio Heart study. Diabetes Care. 2003;26:3153-9.
3. Wannamethee S, Shaper A, Lennon L, Morris R. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med. 2005;165:2644-50.
4. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-9.
5. Lakka H, Laaksonen H, Lakka T, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709-16.
6. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-607.
7. Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
8. The IDF consensus worldwide definition of the metabolic syndrome [accedido 13 Feb 2006]. Disponible en: http://www.idf.org/webdata/docs/ MetSyndrome_FINAL.pdf
9. Ford E, Giles H, Dietz W. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-9.
10. The DECODE study group. Comparison of three different definitions for the metabolic syndrome in non-diabetic Europeans. Br J Diabetes Vasc Dis. 2005;5:161-8.
11. Álvarez A, López V, Suárez S, Arias T, Prieto MA, Díaz L. Diferencias en la prevalencia del síndrome metabólico según las definiciones del ATP-III y la OMS. Med Clin (Barc). 2005;24:368;70.
12. Ford E. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care. 2005;28:2745-9.
13. He Y, Jiang B, Wang J, Feng K, Chang Q, Fan L, et al. Prevalence of the metabolic syndrome and its relation to cardiovascular disease in elderly Chinese population. J Am Coll Cardio. 2006;47:1588-94.
14. Athyros V, Ganotakis E, Elisaf M, Mikhailidis D. The prevalence of the metabolic syndrome using the National Cholesterol Program and International Diabetes Federation definitions. Curr Med Res Opin. 2005;21:1157-9.
15. De la Sierra A, Romero R, Bonet J, Pérez M, López JS, Ravella R, et al. Prevalencia y características del síndrome metabólico en la población hipertensa española. Med Clin (Barc). 2006;126:406-9.
16. Maggi S, Noale M, Gallina P, Bianchi D, Marzari C, Limongi F, et al. Metabolic syndrome, diabetes, and cardiovascular disease in an elderly Caucasian cohort: The Italian longitudinal Study on Aging. J Gerontol A Biol Sci Med Sci. 2006;61:505-10.
17. Adams J, Appleton S, Wilson D, Taylor AW, Dal Grande E, Chittleborough C, et al. Population comparison of two clinical approaches to the metabolic syndrome: implications of the new International Diabetes Federation consensus definition. Diabetes Care. 2005;28:2777-9.
18. Dey DK, Lissner L. Obesity in 70-year-old subjects as a risk factor for 15-year coronary heart disease incidence. Obes Res. 2003;11:817-27.
19. Lawlor D, Ebrahim S, Smith D. The metabolic syndrome and coronary heart disease in older women: findings from the British Women's Heart and Health Study. Diabet Med. 2004;21:906-13.
20. Lawlor D, Davey G, Ebrahim S. Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women's Heart and Health Study. Diabetologia. 2006;49:41-8.
21. McNeill A, Katz R, Girman CJ, Rosamond WD, Wagenknecht LE, Barzilay JI, et al. Metabolic syndrome and cardiovascular disease in older people: The Cardiovascular Health Study. J Am Geriatr Soc. 2006;54:1317-24.
22. Franklin S, Gustin W, Wong N, Larson MG, Weber MA, Kannel WB, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation. 1997;96:308-15.
23. Seidell JC, Visscher TL. Body weight and weight change and their health implications for the elderly. Eur J Clin Nutr. 2000;54:S33-9.